Previous 10 | Next 10 |
Health Catalyst Powers $1.5 Billion in Validated Measurable Improvements PR Newswire 300 Customer Case Studies Document Health Catalyst's Efforts to Power Clinical, Operational, and Financial Improvements SALT LAKE CITY , June 23, 2022 /PRNews...
Telehealth providers are trading sharply higher on Thursday despite a year-to-date selloff driven by concerns over the durability of pandemic-era growth as normalcy returns with the relaxation of COVID-related restrictions. Notable gainers include 1Life Healthcare (ONEM), Teladoc Health (NYSE...
Health Catalyst, Inc. (HCAT) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sac...
Healthcare data and analytics technology and services provider Health Catalyst (NASDAQ:HCAT) has acquired ARMUS Corp. for an undisclosed sum. ARMUS provides data abstraction, data validation, data management, data submission, and data reporting services to support participation in clinic...
Health Catalyst Acquires ARMUS; Bolsters Clinical Quality Offering and Outsourced Services PR Newswire SALT LAKE CITY , May 11, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technolo...
Image source: The Motley Fool. Health Catalyst Inc (NASDAQ: HCAT) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Health Catalyst Inc (HCAT) Q1 2022 Earnings Call Transcript
Health Catalyst press release (NASDAQ:HCAT): Q1 Non-GAAP EPS of -$0.06 beats by $0.05. Revenue of $68.09M (+21.9% Y/Y) beats by $2.08M. For Q2: Revenue is expected to be between $68.0M and $71.0M (vs. consensus of $70.92M). For FY22: Revenue is expected to be between $287.8M and $292.8M (vs. ...
SALT LAKE CITY, May 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2022. “I...
SALT LAKE CITY, April 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2022 operating results on Tuesday, May 10, 2022, after mar...
Citi Investment Research has grouped telehealth provider, Teladoc Health (NYSE:TDOC) and membership-based primary care platform 1Life Healthcare (ONEM) among health tech stocks highly exposed to the risk of a recession. This month, the economists polled by The Wall Street Journal...
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Announces New Credit Facility for up to $225,000,000 PR Newswire SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...